GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Editas Medicine Inc (STU:8EM) » Definitions » Accumulated other comprehensive income (loss)

Editas Medicine (STU:8EM) Accumulated other comprehensive income (loss) : €-0.41 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Editas Medicine Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Editas Medicine's Accumulated other comprehensive income (loss) for the quarter that ended in Jun. 2024 was €-0.41 Mil.

Editas Medicine's quarterly Accumulated other comprehensive income (loss) declined from Dec. 2023 (€0.18 Mil) to Mar. 2024 (€-0.30 Mil) and declined from Mar. 2024 (€-0.30 Mil) to Jun. 2024 (€-0.41 Mil).

Editas Medicine's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-0.44 Mil) to Dec. 2022 (€-3.40 Mil) but then increased from Dec. 2022 (€-3.40 Mil) to Dec. 2023 (€0.18 Mil).


Editas Medicine Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Editas Medicine's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Editas Medicine Accumulated other comprehensive income (loss) Chart

Editas Medicine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 -0.04 -0.44 -3.40 0.18

Editas Medicine Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.11 -1.36 0.18 -0.30 -0.41

Editas Medicine Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Editas Medicine Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Editas Medicine's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Editas Medicine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Editas Medicine Inc (STU:8EM) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
11 Hurley Street, Cambridge, MA, USA, 02141
Editas Medicine Inc is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Editas Medicine Headlines

No Headlines